Mark R. Alderson
Mark R. Alderson publishes mostly in Immunology, Epidemiology and Microbiology, on topics such as Pneumonia and Respiratory Infections, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.
- World rank
- #129,578 of 7,710,434 ranked researchers
- Rank in United States
- #49,213 of 1,627,098
- Works
- 139
- Citations
- 15k
- Citations per work
- 108.8
What does Mark R. Alderson research?
Mark R. Alderson's work is mostly in Medicine (40%), Immunology and Microbiology (38%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences6345.2%
- Health Sciences5640.0%
- Medicine5640.0%
- Everything else2114.8%
- 1Immunology31% of their works
- 2Epidemiology30% of their works
- 3Microbiology7% of their works
- 4Infectious Diseases7% of their works
- 5Molecular Biology7% of their works
- 6Oncology3% of their works
Research topics
Which keywords describe Mark R. Alderson's research?
The keywords of their largest research topics: Epidemiology, Immunity, Vaccine, Diagnosis, Treatment, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine and Natural Killer Cells.
- Mycobacterium avium
- Neisseria meningitidis
- Bacterial Meningitis
- Foxp3
- Mycobacterium tuberculosis
- Cancer Immunotherapy
- NK Cell Recognition
- Community-Acquired Pneumonia
- Diagnosis
- Immunity
- Epidemiology
- Vaccine
- Treatment
- Pneumococcal Conjugate Vaccine
- Natural Killer Cells
- Dendritic Cells
- Tuberculosis
- TGF-ß
- Human Metapneumovirus
- Respiratory Syncytial Virus
- Nontuberculous Mycobacteria
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Epidemiology1305 topics
- Immunity482 topics
- Vaccine482 topics
- Diagnosis462 topics
- Treatment462 topics
- Community-Acquired Pneumonia401 topic
- Pneumococcal Conjugate Vaccine401 topic
- NK Cell Recognition341 topic
- Natural Killer Cells341 topic
- Cancer Immunotherapy261 topic
- Dendritic Cells261 topic
- Mycobacterium tuberculosis261 topic
- Tuberculosis261 topic
- Foxp3241 topic
- TGF-ß241 topic
- Bacterial Meningitis221 topic
- Human Metapneumovirus221 topic
- Neisseria meningitidis221 topic
- Respiratory Syncytial Virus221 topic
- Mycobacterium avium201 topic
- Nontuberculous Mycobacteria201 topic
Where does Mark R. Alderson work?
Mark R. Alderson's main affiliation in the publication record is Program for Appropriate Technology in Health, United States.
How many publications and citations does Mark R. Alderson have?
OpenAlex counts 139 works and 15,123 citations for Mark R. Alderson, an h-index of 63, ranking #129,578 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark R. Alderson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.